Spain currently has an average annual health expense of 2,817 euros per person suffering from diabetes and, in 2019, the figure was 2,485 euros, this is an increase of approximately 12 percent in health spending in people with diabetes, according toThe Diabetes Atlas data of the International Diabetes Federation (IDF).
Although this figure has increased, health expenditure on people with diabetes in Spain is slightly lower than the European average, which is 2,893 euros, despite being the second country with the most affected in Europe, behind Germany.This country has a health expense per person of 6,244 euros a year, more than double the Spanish expenditure, a figure that has increased almost 31 percent since 2019.
Likewise, and according to the IDF report, other European countries, with fewer people with diabetes, have an expense higher than that of Spain, such as the United Kingdom (5,493 euros) or France (5,400 euros).These data have also been increased, compared to the figures that these countries had in 2019, 10.3 percent and 15.6 percent, respectively.
The number of people affected by diabetes in the world currently reaches the affected 537 million.Of these, more than 61 million live in the European continent and almost six million are Spanish.
The average prevalence of diabetes in Spain has reached up to 14.8 percent.This has, in addition to the quality of life of the people who suffer, directly on health spending, which in Spain is 5,809 million euros a year, in patients with type 2 diabetes and, according to the growth forecasts of the growth of thedisease, this figure will increase.
Of the 5,809 million euros that are destined to treat patients with type 2 diabetes, 2,143 million are due to the complications derived from the disease, which could be avoided and/or delayed if patients are provided, by the public administration by the public administration, a correct diabetological education.
The president of the Spanish Diabetes Federation (FEDE), Juan Francisco Perán, said that "to have diabetes education programs for the self -control of the pathology, from the moment of diagnosis, and always individually and continued in time, it would help improve the quality of life of the group and its relatives and reduce the national health cost for diabetes. "